Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07454122) titled 'CD5CAR-NK Cells for Refractory Invasive Mold Disease' on March 2.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Fundacion Clinic per a la Recerca Biomedica

Condition: Fungal Infection

Intervention: Genetic: CD5CAR-CBNK

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: May 2026

Target Sample Size: 10

Countries of Recruitment: Spain

To know more, visit https://clinicaltrials.gov/study/NCT07454122

Published by HT Digital Content Services ...